BIOT 154 |
| The use of disposable bioreactors has the potential to increase Genentech's R&D pilot plant capacity, while significantly decreasing installation costs and labor requirements compared to traditional reactor systems. Several studies were performed at scales that ranged from 1 to 400 liters in the WaveŽ bioreactor. Results from large scale monoclonal antibody production demonstrated comparable growth, titer and product quality to that of conventional stainless steel bioreactors. |
|
Upstream Processing: Cell Culture Process Development: Advances in Process Engineering
3:00 PM-5:30 PM, Tuesday, 12 September 2006 Hilton San Francisco -- Imperial A Ballroom, Oral
Division of Biochemical Technology |